- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
TerrAscend’s Subsidiary Gets Dried Cannabis Sales License
TerrAscend announced its subsidiary Solace Health obtained a license to sell dried cannabis by Health Canada.
TerrAscend (CSE:TER) announced its subsidiary Solace Health obtained a license to sell dried cannabis by Health Canada.
As quoted in the press release:
The sales license will permit the Company to launch the Solace Health Marketplace, an e-commerce platform for Canadian patients. The platform will offer multiple brands, cannabis products and strains with varying cannabinoid profiles and will launch in the coming weeks.
Solace Health is also pleased to announce that it has secured in excess of 1,000kg of dried cannabis including 15 different genetic strains through its own cultivation and strategic industry partnerships.
“This license is an important milestone for the Company that enables us to execute our strategic objectives to deliver both pharmaceutical grade cannabis products and patient support programs” said Dr. Michael Nashat, President and CEO of TerrAscend. “The granting of our sales license, together with the recent expansion of our Mississauga, Ontariofacility, allows us the opportunity to provide the highest quality products with a same day delivery option.”
Click here to read the full press release.
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.